BioZAP
Our technology is a 3D microfluidic tumor array platform which will be used for personalized medicine by evaluating the therapeutic response of biopsy samples. Zeynep Dereli-Korkut
Read MoreAmyloCap
W Vallen Graham has harnessed a novel method to capture native protofibrillar amyloid structures to make a library of conformation-specific monoclonal antibodies that detect early amyloid disease. AmyloCap Team: W. Vallen Graham
Read MoreGesTherapy
The mission of GesTherapy is to use low cost technologies to create affordable tele-health systems for millions of patients worldwide. GesTherapy Team: Tanjin Panna David Putrino
Read MoreQuikiks
Quikiks is the first assistive footwear to enable people with physical or cognitive challenges to don and doff their shoes totally hands-free. Quikiks Team: Steven Kaufman
Read MoreOculogica
The EyeBoxCNS technology features a safe, non-invasive four minute test and will provide vital information for critical diagnosis in the emergency room and in places like the home, the sports field, and the battlefield Oculogica Team: Robert Ritlop Adrian Trevisan
Read MoreTirgan BioPharmaceuticals
Focusing on developing new drugs for treatment of Keloid Disorder: 1) reformulating a generic drug into a sustained release product using nano-technology; 2) purifying plant extract to create a new topical cream. Tirgan BioPharmaceuticals Team: Michael Tirgan
Read MoreGirihlet
Our innovation is a method of purifying and sequencing mitochondrial DNA (mtDNA). The objective is to develop mtDNA biomarkers for neurological disorders and drug-resistance in cancer. Girihlet Team: Anitha Jayaprakash Ravi Sachidanandam
Read MoreBonbouton
Bonbouton develops a smart insole with proprietary embedded graphene sensors monitoring the patient’s feet health. It helps to prevent foot ulcers and reduce the frequency of physician visits. If you are wearing the insole, you may allow access to the application to your friend, insurance company or physician to monitor your daily activity. Bonbouton Team:…
Read MoreImmuneTarget, Inc.
Our mission at ImmuneTarget is to develop novel Rel/NF-kB inhibitor drugs for cancer and autoimmune diseases. ImmuneTarget, Inc. Team: Hsiou-Chi Liou Samedy Ouk
Read More